EchoCath Granted Temporary Exception By NASDAQ.

PRINCETON Princeton, borough (1990 pop. 12,016) and surrounding township (1990 pop. 13,198), Mercer co., W central N.J.; settled late 1600s, borough inc. 1813, township est. 1838. A leading education center, it is the seat of Princeton Univ. , N.J.--(BUSINESS WIRE)--Oct. 3, 1997--EchoCath Inc. (NASDAQ NASDAQ
in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ECHTA) said Friday that its common stock will continue to be listed on the Nasdaq SmallCap Market via an exception from the capital and surplus requirement.

While EchoCath failed to meet this requirement as of May 31, 1997, the company was granted a temporary exception from this standard subject to EchoCath meeting certain conditions.

The exception will expire expire /ex·pire/ (ek-spi´er)
1. to exhale.

2. to die.

ex·pire
v.
1. To breathe one's last breath; die.

2. To exhale. on Oct. 31, 1997. In the event the company is deemed to have met the terms of the exception, it shall continue to be listed on the Nasdaq SmallCap Market.

The company believes that it can meet these conditions, however, there can be no assurance that it will do so. If at some future date the company's securities should cease to be listed on the Nasdaq SmallCap Market, they may continue to be listed in the OTC Bulletin Board OTC Bulletin Board

An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. .

For the duration of the exception, the company's Nasdaq symbol will be ECHAC. The symbol for the company's units, A warrants and B warrants will be ECHUC, ECHWC and ECHZC, respectively.

CONTACT: Allen Al·len , Edgar 1892-1943.

American anatomist who is noted for his studies of hormones and for the discovery (1923) of estrogen. & Caron Inc.

Kent Broussard (investors)

Owen Daley (media)

714/252-8440

or

EchoCath Inc.

Frank A. DeBernardis

609/987-8400

COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Publication:	Business Wire
Date:	Oct 3, 1997
Words:	198
Previous Article:	The Quebec Government Entrusts its Long-Distance Calls to fONOROLA.
Next Article:	Sepragen Records $500,000 in Orders for September.

Related Articles
EchoCath receives U.S. Patent for new EchoFlow technology.
EchoCath receives grant from National Institutes of Health to test new blood-flow measuring system.
EchoCath reports year-end results.
EchoCath reports second quarter, six-month results.
EchoCath Reports Fiscal 1997 Year-End Results.
EP MedSystems Third Quarter Revenue Exceeds $2 Million.
EchoCath Prevails in EPMedSystems Complaint.
Miami Subs Granted Temporary Exception to Nasdaq Minimum Bid Price Requirement; Stock to Begin Trading On the Nasdaq SmallCap Market.
Statement by EchoCath Inc.
EchoCath Announces Short-Term Secured Financing Transaction.